Prevalence of HBV and HCV among outpatients in the plovdiv region of Bulgaria, 2010-2011

Journal of Medical Virology

Volumn 87, Issue 3, 2015, Pages 401-406

  Kevorkyan, Ani ^a   Teoharov, Pavel ^b   Lernout, Tinne ^c   Petrova, Nedyalka ^a   Raycheva, Ralitsa ^a   Ivanov, Ivailo ^b   van Damme, Pierre ^c   Kojouharova, Mira ^b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Hepatitis B; Hepatitis C; Seroprevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; BULGARIA; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NONHUMAN; OUTPATIENT; RURAL AREA; SEROLOGY; SEROPREVALENCE; URBAN AREA; VIRUS LOAD; YOUNG ADULT; AGED; BLOOD; UTILIZATION; VACCINATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ADULT; AGED; BULGARIA; CROSS-SECTIONAL STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 84921354176     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24065     Document Type: Article

References (26)

1. Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY. 2005. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 42:188-194.
2. Alavian S, Fallahian F, Lankarani K. 2007. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16:403-406.
3. Asl Hosseini SK, Avijgan M, Mohamadnejad M. 2004. High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-e-Kord. Arch Iranian Med 7:20-22.
4. Atanasova M, Haydouchka I, Zlatev S, Stoilova Y, Iliev Y, Mateva N. 2004. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. Minerva Gastroenterol Dietol 50:89-96.
5. Beasley RP, Hwang LY. 1983. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 147:185-190.
6. Davis GL, Weber DJ, Lemon SM. 1989. Horizontal transmission of hepatitis B virus. The Lancet 333:889-893.
7. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. 2000. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 18:2345-2350.
8. ECDC: Technical report. Hepatitis B and C in the neighbourhood: burden of disease and screening policies. September, 2010. Available from: http://www.ecdc.europa.eu/en/publications/Publications/TER_100914_Hep_B_C%20_EU_neighbourhood.pdf
9. EMCDDA: Country report. 2011. Available from: http://www.emcdda.europa.eu
10. Fitzsimons D, Kojouharova M, Hallauer J, Hendrickx G, Vorsters A, Van Damme P. 2011. Burden and prevention of viral hepatitis in Bulgaria. Vaccine 29:8471-8476.
11. Gane E. 2005. Screening for chronic hepatitis B infection in New Zealand: unfinished business. J N Z Med Assoc 118:1211.
12. Hajioff S, McKee M. The health of the Roma people: a review of the published literature. European Centre on Health of Societies in Transition. Available from: http://health.osf.lt/en/archive/2000/roma_november/background/hajioff_lit_review.htm#_edn38
13. Health strategy for socially unequal individuals from ethnic minorities, Available from: http://www.nccedi.government.bg/upload/docs/zdravna_strategia_prieta.htm [In bulgarian].
14. Kojouharova M, Petrova G, Kurchatova A. 2011. Cost-benefit analyses. VHPB meeting on Burden and prevention of viral hepatitis in Bulgaria, Sofia, Bulgaria. Viral Hepatitis 20:16-17.
15. McMahon BJ. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49:S45-S55.
16. National anti-drug strategy, of the Republic of Bulgaria 2003-2008. Available from: http://www.mvr.bg/nr/rdonlyres/180916cf-e238-4070-ad6e-9da40d743aca/0/02_nationalantidrugstrategy20032008_eng.pdf
17. National Strategy for Control and Prevention of HIV and other sexually transmitted diseases. 2001-2007; Sofia, 2002; BUL/98/005 [In Bulgarian].
18. Petrunov B, Kojouharova M, Teoharov P, Haidushka I, Sotirova P, Sredkova M, Russev I, Zacharakis G, Tzara F, Vafeadis N, Papathanasiou J, Papoutselis K. 2002. EU project Interreg II: Seroepidemiology study on Hepatitis C and B viral infections prevalence in Bulgaria and Northern Greece. J Hepatol 36: Abstract 497.
19. Regulation No 15 of 12 May 2005 on the immunisations in the Republic of Bulgaria, promulgated in State Gazette No 45 of 31 May 2005 [In bulgarian].
20. Stroffolini T. 2005. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 37:622-627.
21. Theeten H, Hutse V, Hoppenbrouwers K, Beutels P, Van Damme P. 2013. Universal hepatitis B vaccination in Belgium: Impact on serological markers 3 and 7 years after implementation. Epidemiol Infect 21:1-11.
22. Vitro Ruiz MT, Marin Alcala MP, Pascual Val T, Lopez Morras C, Aramburu Bergua I, Zubicoa Ventura J. 1993. Endemic hepatitis B in 2 marginal ethnic minorities. Comparative study. Med Clin (Barc) 101:245-248.
23. Vladimirova N, Andonov A, Teoharov P, Kevorkian A. 2011. Epidemiology. VHPB meeting on burden and prevention of viral hepatitis in Bulgaria, Sofia, Bulgaria. Viral Hepatitis 20:8-12.
24. World Health Organization. 2010. Hepatitis B vaccines: WHO position paper-recommendations. Vaccine 28:589-590.
25. Yildirim B, Barut S, Bulut Y, Yenişehirli G, Ozdemir M, Cetin I, Etikan I, Akbaş A, Atiş O, Ozyurt H, Sahin S. 2009. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. Turk J Gastroenterol 20:27-30.
26. Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, Du B, Wang W, Shi X, Zhang S, Li W, Jiang Y, Feng J, He S, Niu J. 2011. Seroprevalence and risk factors for Hepatitis B infection in an Adult Population in Northeast China. Int J Med Sci 8:321-331.